UroMems, a developer and manufacturer of electronic artificial urinary sphincters (eAUS), has raised €16m (US$17.7m) Series B funding which included a combination of equity and debt financing. The financing round was led by Hil-Invent, with co-investor Financière Arbevel. Existing UroMems investors, including Wellington Partners, Bpifrance, via its FABS fund, Cita Investissement, Supernova Invest and btov…
©2023 All rights reserved LaingBuisson 
, has raised €16m (US$17.7m) Series B funding){kind=link}